Insider Trading & Ownership of Rahul Singhvi

Location
Chalfont, PA
Summary
The estimated net worth of Rahul Singhvi is at least $399,495 dollars as of 26 Nov 2025. Rahul Singhvi is the Director of CODEXIS, INC. and owns shares of CODEXIS, INC. (CDXS) stock worth about $345.4K. Rahul Singhvi is the Director of Kairos Pharma, LTD. and owns shares of Kairos Pharma, LTD. (KAPA) stock worth about $54.1K.
Signature
/s/ Rahul Singhvi
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Rahul Singhvi and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Rahul Singhvi has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $399,495.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CODEXIS, INC. ($345,371).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Rahul Singhvi

CDXS Forms 3/4/5

CODEXIS, INC.

Relationship
Director
Holdings value
$345,371
Past year net change
Change %
Report period
10 Jun 2025
KAPA Forms 3/4/5

Kairos Pharma, LTD.

Relationship
Director
Holdings value
$54,124
Past year net change
Change %
Report period
08 Oct 2025

Insider Transactions Reported by Rahul Singhvi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .